Xacduro

Warnings and Precautions for Xacduro

Xacduro does not carry a formal FDA boxed warning. However, patients and prescribers should be aware of the following important safety information.

Hypersensitivity Reactions

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported with beta-lactam antibacterials, including Xacduro. Before initiating treatment, careful inquiry should be made about prior hypersensitivity reactions.

Clostridioides difficile-Associated Diarrhea

Clostridioides difficile-associated diarrhea has been reported with nearly all antibacterial agents, including Xacduro, and can range from mild to life-threatening.

Development of Drug-Resistant Bacteria

Prescribing Xacduro in the absence of a confirmed or strongly suspected bacterial infection is unlikely to provide benefit and increases the risk of developing drug-resistant bacteria.

How to Access Xacduro in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation and Availability of Xacduro

Xacduro is manufactured and marketed by La Jolla Pharmaceutical Company, an Innoviva company. It is sourced through authorized distribution channels for patients seeking named-patient import into India.

Required Documentation

Patients typically need a valid prescription from a treating infectious disease specialist or intensivist confirming HABP/VABP diagnosis and Acinetobacter species testing where available. NPP's regulatory team assists in preparing and verifying the documentation needed for a compliant import.

Availability

As an FDA-approved therapy for Acinetobacter-related hospital-acquired pneumonia, Xacduro is sourced through authorized channels and imported under GDP-compliant, cold-chain logistics to preserve product quality throughout transit.

Sourcing and Delivery of Xacduro

NPP sources Xacduro directly from authorized pharmaceutical distributors to ensure product authenticity and full traceability. Every shipment is handled under Good Distribution Practice (GDP) conditions from origin to the patient's doorstep.

Cold Chain and Handling

Xacduro requires refrigerated storage at 2°C to 8°C, with brief exposure to 8°C to 15°C permitted. NPP maintains appropriate cold-chain handling throughout transit.

Delivery Timelines

Once documentation and regulatory approvals are in place, delivery timelines are communicated transparently at the time of quotation, accounting for import clearance and last-mile cold-chain logistics to the patient's city.

Availability of Xacduro Across Major Cities in India

Patients across India can access Xacduro through NPP's regulated import pathway, with critical care and infectious disease specialists in major cities supporting the treatment process.

Mumbai

Leading hospitals in Mumbai support critical care and infectious disease coordination and documentation for Xacduro access.

Delhi

Delhi's major hospitals assist patients with prescription support and documentation for Xacduro.

Bangalore

Bangalore's specialist network offers access coordination for eligible patients seeking Xacduro.

Chennai

Chennai-based infectious disease specialists coordinate Xacduro access alongside comprehensive critical care.

Hyderabad

Hyderabad's care institutions support patients pursuing Xacduro therapy.

Kolkata

Kolkata's specialist centers help coordinate documentation and treatment access for Xacduro.

Pune

Pune-based specialists assist with prescription support and Xacduro treatment planning.

Ahmedabad

Ahmedabad's specialty hospitals support the import and treatment process for Xacduro.

Kochi

Kochi's specialist units assist patients with the documentation needed for Xacduro access.

Chandigarh

Chandigarh's care centers support Xacduro treatment coordination for patients from North India.

Jaipur

Jaipur's specialists help patients navigate the Xacduro access process.

Lucknow

Lucknow-based centers assist patients pursuing Xacduro therapy.

Bhubaneswar

Bhubaneswar's institutions support access to Xacduro for eligible patients.

Guwahati

Guwahati's specialists help coordinate Xacduro access for patients across the Northeast.

Patients in other cities across India can also access Xacduro through NPP's nationwide coordination network.